General Biotechnology

Antibacterials: a dying trade : Despite strong worldwide demand for effective antibacterial products, sustaining growth within this segment will become […]

Financial Snapshot For June 2003: Taking A Breather

Pfizer’s Quest to Stay Ahead of the Pack The drugmaker has been a stable holding in unstable times. Now, though,

Pfizer’s Quest to Stay Ahead of the Pack The drugmaker has been a stable holding in unstable times. Now, though,

Can Your Genomics Work Contribute to Biodefense Three years ago, Luis Villarreal, a virologist at the University of California, Irvine,

Biogen/Idec: still a matter of size The merger of Biogen and Idec Pharmaceuticals, announced June 23, is likely to help

The State of Biotechnology Researchers, government officials and industry executives will gather this weekend in Washington for the Biotechnology Industry

Coffee Plants Can Produce Less Caffeine Researchers say they have genetically engineered coffee plants that have 70 percent less caffeine

Pfizer’s Outlook Improves Having spent $5 billion on research and development in 2002, Pfizer (NYSE: PFE) is king of the

Pfizer’s Outlook Improves Having spent $5 billion on research and development in 2002, Pfizer (NYSE: PFE) is king of the